Cancer/Testis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia Virus
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Carcinoma
Interventions: BIOLOGICAL: rVV-740CTA
Sponsor: University Hospital, Basel, Switzerland